De/te-opioid ligands reverse alfentanil-lnduced respiratory depression but not antinociception

Journal of Pharmacology and Experimental Therapeutics

Volumn 287, Issue 3, 1998, Pages 815-823

  Su, Ying Fu ^a,b   McNutt, Robert W ^b,c   Chang, Kwen Jen ^d,e  

^a Departments of Anesthesiology and Pharmacology   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Division of Chemistry   (United States)

^d GLAXOSMITHKLINE   (United States)

^e Delta Pharmaceuticals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA [4 (2 BUTENYL) 3,5 DIMETHYL 1 PIPERAZINYL] 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; ALFENTANIL; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LIGAND; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NALTRINDOLE; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; DRUG DERIVATIVE; NALTREXONE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST; OLIGOPEPTIDE; PHENYLALANYL CYCLO(CYSTEINYLTYROSYL TRYPTOPHYL ORNITHYL THREONYL PENICILLAMINE)THREONINAMIDE; PHENYLALANYL-CYCLO(CYSTEINYLTYROSYL-TRYPTOPHYL-ORNITHYL-THREONYL-PENICILLAMINE)THREONINAMIDE; PIPERAZINE DERIVATIVE; SOMATOSTATIN; TYROSYL TETRAHYDROISOQUINOLINECARBONYL PSI(METHYLAMINO)PHENYLALANYL PHENYLALANINE; TYROSYL-TETRAHYDROISOQUINOLINECARBONYL-PSI(METHYLAMINO)PHENYLALANYL-PHENYLALANINE;

ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; HYPERCAPNIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATION DEPRESSION; TAIL FLICK TEST; ANIMAL; BREATHING; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; RESPIRATORY FAILURE; SPRAGUE DAWLEY RAT;

ALFENTANIL; ANALGESICS, OPIOID; ANIMALS; BENZAMIDES; HYPERCAPNIA; LIGANDS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NARCOTICS; OLIGOPEPTIDES; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; RESPIRATION; RESPIRATORY INSUFFICIENCY; SOMATOSTATIN;

EID: 0032240294     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Berger AJ, Mitchell RA and Severinghaus JW (1977) Regulation of respiration. NEngl JMed 297:92-97.
2. Bishop M and McNutt RW (1995) An efficient synthesis of the benzhydrylpiperazir e delta opioid agonist ( + )-BW373U86. Bioorg Med Chem 5:1311-1314.
3. Bonham AC (1995) Neurotransmitters in the CNS control of breathing. Res Physwl 101:219-230.
4. Butelman ER, France CP and Woods JH (1993) Apparent pA2 analysis on tre respiratory depressant effects of alfentanil, etonitazene, ethylketocyclazocine (EKC) and MR2033 in rhesus monkeys. J Pharmacol Exp Ther 264:145-151.
5. Chang K-J, Rigdon GC, Howard JL and McNutt RW (1993) A novel, potent and selective nonpeptidic 8-opioid receptor agonist BW373U86. J Pharmacol Exp Thtr 267:852-857.
6. Cheng PY, Wu DL, Decena J, Cheng Y, Mccabe S and Szeto HH (1992) Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D-Pen2, D-Pen5|enkephalin and partial antagonism by naltrindole. J Pharmacol Exp Ther 26II: 1004-1010.
7. Cheng PY, Wu D, Decena J, Soong Y, Mccabe S and Szeto HH ( 1993a) Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I. Eur J Pharmacol 230:85-88.
8. Cheng PY, Wu D, Soong Y, Mccabe S, Decena JA and Szeto HH (1993b) Role of mu 1 and delta-opioid receptors in modulation of fetal EEG and respiratory activitv. Am J Physiol 265:R433-R438.
9. Erspamer V, Melchiorri P, Falconieri-Erspamer G, Negri L, Corsi R, Severini C, Barra D, Simmaco M and Kreil G (1989) Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding site. Proc Natl Acad Sei USA 86:5188-5192.
10. Feuerstein G and Faden AI (1983) Central autonomie effects of dermorphin in conscious rats. J Pharmacol Exp Ther 226:151-156.
11. Freye E, Schnitzler M and Schenk G (1991) Opioid-induced respiratory depression and analgesia may be mediated by different subreceptors. Pharm Res 8:196-199.
12. Freye E, Latasch L and Portoghese PS (1992) The delta receptor is involved in sufentanil-induced respiratory depression-opioid subreceptors mediate different effects. Eur J Anaesthesiol 9:457-462.
13. Haddad GG, Gandhi MR, Hochward GM and Lai TL (1982) Enkephalin-induced changes in ventilation and ventilatory pattern in adult dogs. J Appl Physiol 55:1311-1320.
14. Haddad GG, Schaeffer JI and Chang KJ (1984) Opposite effects of the delta- and mu-receptor agonists on ventilation in conscious adult dogs. Brain Res 323:73-82.
15. Hassen AH, Feuerstein G and Faden AI (1982) Mu receptors and opioid cardiovascular effects in the NTS of rat. Peptides 3:1031-1037.
16. Hassen AH, Feuerstein G and Faden AI (1984) Selective cardiorespiratory effects mediated by mu opioid receptors in the nucleus ambiguus. Neuropharmacology 23:407-415.
17. Hawkins KN, Knapp KJ, Lui GK, Gulya K, Kazmierski W, Wan YP, Pelton JT, Hruby VJ and Yamamura HI (1989) [3H]-[H-D-Phe-Cys-Tyr-Orn-Thr-Pen-ThrNH2) ([3H]CTOP), a potent and highly selective peptide for mu opioid receptors i:i rat brain. J Pharmacol Exp Ther 248:73-80.
18. Holaday JW (1982) Cardiorespiratory effects of mu and delta opiate agonists following third or fourth ventricular injections. Peptides 3:1023-1029.
19. Hurle MA, Mediavilla A and Florez J (1985) Differential respiratory patterns induced by opioids applied to the ventral medullary and dorsal pontine surfaces cf cats. Neuropharmacology 24:597-606.
20. McGilliard KL and Takemori AE (1978) Antagonism by naloxone of narcotic-induced respiratory depression and analgesia. J Pharmacol Exp Ther 207:494-503.
21. Morin-Surun M-P, Boudinot E, Gacel G, Champagnat J, Roques BP, and DenavitSaubie M ( 1984) Different effects of mu and delta opiate agonists on respiration. Eur J Pharmacol 98:235-240.
22. Mosberg HI, Hurst R, Hruby VI, Gee K, Yamamura HI, Galliga JJ and Burks TF (1983) Bis-penicillamine enkephalins show pronounced delta receptor selectivitj. Proc Natl Acad Sei USA 80:5871-5874.
23. Mueller RA, Lundberg DB, Breese GR, Hedner J, Hedner T and Jonason J (1982) The Neuropharmacology of Respiratory Control. Pharmacol Rev 34:255-285.
24. Paakkari P, Paakkari I, Siren AL and Feuerstein G (1990) Respiratory and locomotor stimulation by low doses of dermorphin, a mu 1 receptor-mediated effect. J Pharmacol Exp Ther 252:235-240.
25. Paakkari P, Paakkari I, Vonhof S, Feuerstein G and Siren AL (1993) Dermorphin analog Tyr-D-Arg2-Phe-Sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors? J Pharmacol Exp Ther 266:544-550.
26. Pasternak GW (1986) Multiple morphine and enkephalin receptors: biochemical and pharmacological aspects. Ann NY Acad Sei 467:130-139.
27. Pazos A and Florez J (1984) A comparative study in rats of the respiratory depression and analgesia induced by mu- and delta-opioid agonists. Eur J Pharmacol 99:1521.
28. Pelton JT, Kazmierski W, Gulya K, Yamamura HI and Hruby VJ (1986) Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for mu opioid receptors. J Med Chem 29:2370-2375.
29. Pfeiffer A, Feuerstein G, Kopin IJ and Faden AI (1983) Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats. J Pharmacol Exp Ther 225:735741.
30. Portoghese PS, Sultana M and Takemori AE (1988) Naltrindole, a highly selective and potent non-peptide delta opioid receptor antagonist. Eur J Pharmacol 146: 185-186.
31. Portoghese PS (1991) An approach to the design of receptor-type-selective nonpeptide antagonists of peptidergic receptors: delta opioid antagonists. J Med Cherr, 34:1757-1762.
32. Reisine T and Pasternak G (1996) Opioid Analgesics and Antagonists, in Goodman and Oilman's The Pharmacological Basis of Therapertics, 9th ed. (Hardman JG and Limbird LE, eds), pp 521-555, MacGraw-Hill, New York, NY.
33. Schaeffer JI and Haddad GG (1985) Regulation of ventilation and oxygen consumption by delta- and mu-opioid receptor agonists. J Appl Physiol 59:959-968.
34. Schiller PW, Weltrowska G, Nguyen TM, Wilkes BC, Chung NN and Lemieux C (1993) TIPPi/i: A highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. J Med Chem 36:3182-3187.
35. Shook JE, Watkins WD and Camporesi EM (1990) Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis 142:895-909.
36. Ward SJ and Takemori AE (1983) Determination of the relative involvement of mu-opioid receptors in opioid-induced depression of respiratory rate by use of beta-funaltrexamine. Eur J Pharmacol 87:1-6.
37. Wild KD, McCormick J, Bilsky EJ, Vanderah T, McNutt RW, Chang KJ and Porreca F (1993) Antinociceptive actions of BW373U86 in the mouse. J Pharmacol Exp Ther 267:858-865.
38. Wong CS, Su Y-F, Watkins WD and Chang K-J (1992) Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium ion and guanine nucleotides on -opioid receptor binding of rat spinal membranes. J Pharmacol Exp Ther 262:317-326.
39. Yeadon M and Kitchen 1 (1990) Multiple opioid receptors mediate the respiratory depressant effect of fentanil-like drugs in the rat. Gen Pharmacol 21:655-664.